Brits travelling to Spain can enter the country without having to prove their Covid or vaccination status.
Brits travelling to Spain can enter the country without having to prove their Covid or vaccination status, after travel restrictions were dropped.
The Spanish Healthy Ministry announced on Thursday that people entering from outside the European Union would no longer be subject to the controls, effective from Friday. The requirement for children over the age of 12 to be double vaccinated to enter the Spanish mainland was only scrapped just before the February half-term, after tourism businesses warned that it was driving families to book trips to other countries instead.Travel firms have continued to report strong demand for bookings, despite the cost of living pressures affecting households, with Heathrow Airport saying it expects Christmas to be busy.
Danmark Seneste Nyt, Danmark Overskrifter
Similar News:Du kan også læse nyheder, der ligner denne, som vi har indsamlet fra andre nyhedskilder.
Spain makes major change to Covid travel rules ahead of half-term holidayTravellers will no longer have to prove they're vaccinated to pass the Spanish boarders
Læs mere »
Major boost for Brits after Spain lifts all Covid restrictions for holidaymakersSPAIN has lifted all its Covid travel restrictions for holidaymakers with immediate effect. The decision comes into effect from today and will be welcome news for the thousands of Brits planning a …
Læs mere »
All Covid restrictions lifted for Brits travelling to SpainBreaking: All Covid restrictions lifted for Brits travelling to Spain
Læs mere »
Risk of thyroid dysfunction associated with mRNA and inactivated COVID-19 vaccines: a population-based study of 2.3 million vaccine recipients - BMC MedicineBackground In view of accumulating case reports of thyroid dysfunction following COVID-19 vaccination, we evaluated the risks of incident thyroid dysfunction following inactivated (CoronaVac) and mRNA (BNT162b2) COVID-19 vaccines using a population-based dataset. Methods We identified people who received COVID-19 vaccination between 23 February and 30 September 2021 from a population-based electronic health database in Hong Kong, linked to vaccination records. Thyroid dysfunction encompassed anti-thyroid drug (ATD)/levothyroxine (LT4) initiation, biochemical picture of hyperthyroidism/hypothyroidism, incident Graves’ disease (GD), and thyroiditis. A self-controlled case series design was used to estimate the incidence rate ratio (IRR) of thyroid dysfunction in a 56-day post-vaccination period compared to the baseline period (non-exposure period) using conditional Poisson regression. Results A total of 2,288,239 people received at least one dose of COVID-19 vaccination (57.8% BNT162b2 recipients and 42.2% CoronaVac recipients). 94.3% of BNT162b2 recipients and 92.2% of CoronaVac recipients received the second dose. Following the first dose of COVID-19 vaccination, there was no increase in the risks of ATD initiation (BNT162b2: IRR 0.864, 95% CI 0.670–1.114; CoronaVac: IRR 0.707, 95% CI 0.549–0.912), LT4 initiation (BNT162b2: IRR 0.911, 95% CI 0.716–1.159; CoronaVac: IRR 0.778, 95% CI 0.618–0.981), biochemical picture of hyperthyroidism (BNT162b2: IRR 0.872, 95% CI 0.744–1.023; CoronaVac: IRR 0.830, 95% CI 0.713–0.967) or hypothyroidism (BNT162b2: IRR 1.002, 95% CI 0.838–1.199; CoronaVac: IRR 0.963, 95% CI 0.807–1.149), GD, and thyroiditis. Similarly, following the second dose of COVID-19 vaccination, there was no increase in the risks of ATD initiation (BNT162b2: IRR 0.972, 95% CI 0.770–1.227; CoronaVac: IRR 0.879, 95%CI 0.693–1.116), LT4 initiation (BNT162b2: IRR 1.019, 95% CI 0.833–1.246; CoronaVac: IRR 0.768, 95% CI 0.613–0.962), hyperthyroidism (BNT162b2: IRR 1.0
Læs mere »